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Activation of muscarinic acetylcholine (ACh) receptors (mAChRs) powerfully affects many
neuronal properties as well as numerous cognitive behaviors. Small neuronal circuits
constitute an intermediate level of organization between neurons and behaviors, and
mAChRs affect interactions among cells that compose these circuits. Circuit activity
is often assessed by extracellular recordings of the local field potentials (LFPs),
which are analogous to in vivo EEGs, generated by coordinated neuronal interactions.
Coherent forms of physiologically relevant circuit activity manifest themselves as rhythmic
oscillations in the LFPs. Frequencies of rhythmic oscillations that are most closely
associated with animal behavior are in the range of 4–80 Hz, which is subdivided into
theta (4–14 Hz), beta (15–29 Hz) and gamma (30–80 Hz) bands. Activation of mAChRs
triggers rhythmic oscillations in these bands in the hippocampus and neocortex. Inhibitory
responses mediated by GABAergic interneurons constitute a prominent feature of these
oscillations, and indeed, appear to be their major underlying factor in many cases.
An important issue is which interneurons are involved in rhythm generation. Besides
affecting cellular and network properties directly, mAChRs can cause the mobilization
of endogenous cannabinoids (endocannabinoids, eCBs) that, by acting on the principal
cannabinoid receptor of the brain, CB1R, regulate the release of certain neurotransmitters,
including GABA. CB1Rs are heavily expressed on only a subset of interneurons and,
at lower density, on glutamatergic neurons. Exogenous cannabinoids typically disrupt
oscillations in the theta (θ) and gamma (γ) ranges, which probably contributes to the
behavioral effects of these drugs. It is important to understand how neuronal circuit activity
is affected by mAChR-driven eCBs, as this information will provide deeper insight into the
actions of ACh itself, as well as into the effects of eCBs and exogenous cannabinoids in
animal behavior. After covering some basic aspects of the mAChR system, this review will
focus on recent findings concerning the mechanisms and circuitry that generate θ and γ
rhythms in hippocampus and neocortex. The ability of optogenetic methods to probe the
many roles of ACh in rhythm generation is highlighted.
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INTRODUCTION
The numerous effects that acetylcholine (ACh) has in the nervous
system are mediated by both muscarinic (mAChR) and nicotinic
(nAChR) receptors. Initially, attention focused on the mAChRs,
following the classical experiments of Otto Loewi that showed
that chemical transmission at synapses in the heart was mediated
by ACh acting at mAChRs. With the recognition that nAChRs
are also present in the brain and are directly relevant to the
understanding of, e.g., the addictive potency of nicotine and its
importance in schizophrenia, an enormous effort has gone into
investigating the nAChRs in the central nervous system, although
work continued on the molecular structure and pharmacology
of the mAChRs. In addition, electrophysiological studies have
provided a wealth of data on their cellular actions, the ion
channels that they control, and their downstream biochemical
mechanisms. Yet, despite these efforts, there remain important
gaps in our knowledge of how the mAChRs affect neuronal
circuits. Neuronal oscillations are among the most prominent
and readily detected signs of neuronal circuit behavior. Certain
oscillations, particularly those in the theta (θ, 4–14 Hz) and
gamma (γ, 30–80 Hz) frequency ranges, are widely believed to
be essential for the performance of various behavioral and cog-
nitive functions. A general cholinergic agonist, carbachol (CCh),
is often used to induce these rhythms which are mediated by
mAChRs in hippocampus and neocortex in model experimen-
tal systems. However, a full understanding of the cellular and
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molecular mechanisms of rhythm generation has not been
achieved. GABAergic inhibitory interneurons are key elements in
rhythm generation, and mAChRs affect their behavior in many
ways.
This review will highlight some new results on the generation
of oscillations in hippocampus and neocortex; useful reviews
of earlier work (e.g., Lawrence, 2008) have appeared. We will
discuss the types of mAChRs, their influence on the some of
the main interneuron subtypes and to lesser extent on principal
cells. An emerging but still under-investigated theme is the ability
of certain mAChRs to stimulate the synthesis and release of
endogenous cannabinoids (endocannabinoids, eCBs), the natural
ligands for the cannabinoid receptors (CB1Rs) in the brain (see
diagram in Figure 1). In many regions, certain interneurons
are heavily invested with CB1Rs while other interneurons have
none; glutamatergic neurons often have far lower densities (up
to 30 times lower) of the CB1Rs than do the interneurons. The
great majority of CB1Rs are located on or near synaptic nerve
terminals where their activation by exogenous cannabinoids and
eCBs inhibit transmitter release. There has been little concerted
effort to understand the implications of the mAChR-eCB link
on complex nervous system activity, however. In view of the
potency of mAChRs to mobilize eCBs, and thereby indirectly
alter neuronal activity, it will be of great interest to work out
the details and functional implications of this association. A
key issue that has been difficult to explore with conventional
methods concerns endogenously released ACh. The bulk of all
experimental work on mAChRs and their physiological effects has
been carried out either with gross tissue stimulation delivered by
extracellular electrodes or perfusion with pharmacological agents.
These methods lack specificity and selectivity of action, and the
conclusions they permit are accordingly limited. We will discuss
recent experiments in which optogenetic techniques have been
used to probe the workings of the ACh system in unprecedented
detail.
CENTRAL CHOLINERGIC PROJECTION NEURONS
ASSOCIATED WITH mAChR-INDUCED RHYTHM GENERATION
Almost all of the ACh in the hippocampus and neocortex comes
from distal axons of cholinergic projection neurons that are highly
concentrated in the basal forebrain (Lewis and Shute, 1967; see
Woolf, 1991; van der Zee and Luiten, 1999; for review). This
collection of nuclei includes the medial septum (MS) and lateral
septum, the horizontal and vertical limb of the diagonal band of
Broca (DBB), and the nucleus basalis magnocellularis (NBM). In
rodents, cholinergic neurons in the MS/DBB project to olfactory-
related structures, cingulate cortex, retrospenial cortex, medial
prefrontal cortex, hippocampus and parahippocampus (Gaykema
et al., 1989). The cholinergic projection from the MS/DBB to
the hippocampus via the fornix/fimbria system is quite large,
and selective ablation of the cholinergic cells in the MS/DBB or
transection of the fimbria-fornix leads to a virtual loss of ACh
fibers in the hippocampus (Lee et al., 1994; Naumann et al.,
1994). Cholinergic neurons in the NBM project to the entire
cortical mantle, with laminar projection patterns varying with
cortical area. NBM also projects to the amygdala and olfactory
bulb (see Woolf, 1991; van der Zee and Luiten, 1999 for reviews).
FIGURE 1 | Schematic summary diagram of the endocannabinoid
system. A presynaptic nerve terminal is shown synapsing on a
postsynaptic cell. Agonist binding of either group I mGluRs or M1 or M3
mAChRs activates phospholipase Cβ (PLCβ) in the postsynaptic cell. The
product of the reaction catalyzed by PLCβ, diacylglycerol (DAG), is
metabolized by the enzyme diacylglycerol lipase α (DGLα) to form the
endocannabinoid, 2-arachidonyl glycerol (2-AG). DGLα can also be activated
by Ca2+ influx via a PLC-independent mechanism. 2-AG is membrane
permeant and gains access through an unknown mechanism to the
cannabinoid receptor, CB1R, on the presynaptic nerve terminal. Binding of
CB1R by 2-AG inhibits transmitter release, mainly by inhibiting Ca2+ influx
into the terminal, although other mechanisms can be involved. This is the
simplest conventional model of the system and various details are
controversial or have been omitted for the sake of simplicity; see a
comprehensive review, e.g., Kano et al. (2009), for more information.
An important anatomical feature of the ACh system in the brain
is that cholinergic fibers only rarely (e.g., 3% in hippocampus
and neocortex, Yamasaki et al., 2010) make classical morpho-
logically defined synapses onto their target neurons (one-to-one,
or “wired transmission”, Zoli et al., 1999). Rather, large vesicle-
filled varicosities appear along the axons, and ACh is released
into the local environment (Vizi and Kiss, 1998), where it diffuses
in a paracrine-like way to receptors on target neurons and glia.
This has been referred to as “volume conduction” (Zoli et al.,
1999) and may be especially relevant for understanding mAChR-
mediated effects, as they tend to have slow kinetics themselves
and may involve the release of other modulators for which rapid
kinetics is also not a key feature. A correlational EM study for
the localization of M1 mAChRs and presynaptic synaptic special-
izations, including the presynaptic active-zone protein, bassoon,
along cortical and hippocampal pyramidal cell (PC) dendrites,
found that, unlike glutamate terminals and AMPA receptors, there
was no close relationship between a cholinergic varicosity (iden-
tified by either the choline transporter, CHT1, or choline acetyl
transferase, ChAT) near a dendrite and postsynaptic clusters of
M1 receptors (Yamasaki et al., 2010). These findings appear to
be consistent with the volume transmission mode. Sarter et al.
(2009) question the relevance of the distinction between wired
and volume transmission, since both can mediate responses with
very slow kinetics, but admit that the difference may still be
significant in the spatial domain—proximity of the release site
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to the receptors—which is the one most relevant to the present
discussion.
DISTRIBUTION, ACTION, AND CELLULAR LOCALIZATION OF
mAChR SUBTYPES IN HIPPOCAMPUS AND NEOCORTEX
Muscarinic acetylcholine receptors (mAChRs) are G-protein cou-
pled receptors of the Class A, rhodopsin-like family, with ACh
being the main endogenous agonist (the ACh precursor, choline,
reportedly induces γ activity in an atropine-sensitive way at 2–
5 mM, Fischer et al., 2014). mAChRs are widely distributed
throughout the central nervous system. The five subtypes, des-
ignated M1-5 (Bonner, 1989; Caulfield and Birdsall, 1998) can be
divided into two broad groups based on their primary coupling
to G-proteins. M1, M3 and M5 receptors (M1-class) are prefer-
entially coupled to Gq/11 proteins and activate phospholipase C,
which initiates the IP3—diacylglycerol (DAG) cascade leading to
intracellular Ca2+ mobilization, and activation of protein kinase
C and mitogen-activated protein kinase (MAPK) pathways. M2
and M4 receptors (M2-class) couple to the pertussis-toxin sensi-
tive Gi/o proteins and inhibit adenylyl cyclase activity.
Although widespread in the brain, there is considerable
regional variability in the distribution of mAChR subtypes.
Throughout the brain, M1 is the most abundant subtype and M5
the least. In the hippocampus and neocortex, M1 is present at high
levels; M3 is present at moderate levels (though generally low else-
where). M4 is very high almost everywhere in the brain, while M2
is found at much lower densities. M5 mRNA is relatively sparse
except in hippocampal CA1 PCs and some scattered subcortical
nuclei. M1-class receptors are often located on somato-dendritic
regions of neurons, and their activation leads to membrane
depolarization and increases in cellular excitability by enhancing
the mixed-cation Na+/K+ current (Ih), Ca2+ -dependent, non-
selective cation current (e.g., Fisahn et al., 2002), and by inhibiting
certain potassium channels, such as Kv7 (M-current), KsAHP, and
K (“leak” channels) (e.g., Brown and Adams, 1980; Cole and
Nicoll, 1983; Halliwell, 1990; Cobb and Davies, 2005; Lawrence
et al., 2006b; Broicher et al., 2008). M2-class receptors frequently
reside on presynaptic axonal terminals (although there are excep-
tions), and agonist binding can activate Kir3 potassium channels
and inhibit some voltage-gated Ca2+ channels (especially Cav2.2),
which in turn hyperpolarizes the neuron or inhibits transmitter
release (Hájos et al., 1998; Brown, 2010) (It should be noted that
cholinergic axon terminals, including the axons of the MS/DBB
fibers, generally express mAChRs, often M2-types, that probably
act as presynaptic autoreceptors and regulate ACh outflow; this
review will not cover this topic and interested readers can consult,
e.g., Vizi and Kiss, 1998; Zoli et al., 1999 for reviews). While the
exact cellular location and functional role of each subtype has
not been fully elucidated, some correlations between different
forms of cholinergic neuromodulation and the neurochemical
identities of distinct neuron classes have been established in both
hippocampus and neocortex.
mAChRs ON PYRAMIDAL CELLS AND INTERNEURONS IN
HIPPOCAMPUS AND NEOCORTEX
In the hippocampal CA1 region, PCs provide excitatory output
to other cortical and subcortical areas, and carry information
about spatial location and episodic memories (e.g., Eichenbaum,
2013). The functions of PCs are supported by local inhibitory
circuits comprising more than 20 types of GABAergic interneu-
rons (Freund and Katona, 2007; Klausberger and Somogyi, 2008;
Whittington et al., 2011). The majority of these interneurons are
morphologically and neurochemically distinct (Klausberger and
Somogyi, 2008), yet their detailed functions have not been worked
out. One broad distinction is based on whether the interneurons
participate in feedback or feedforward inhibition; another is
whether they synapse on dendritic or somatic regions of their
target cells. There is some overlap between these classifications,
with feedforward inhibition often mediated by dendritic targeting
interneurons, and feedback inhibition mediated by perisomatic
(i.e., including the soma and proximal dendrites 50–100 µm
away) regions. However, there are many exceptions to this gener-
alization (Bartos et al., 2011) and we will focus on the dendritic vs.
perisomatic targeting distinction, which seems to be quite general
across many brain regions.
Perisomatic targeting interneurons include two
non-overlapping classes of basket cells (BCs): the parv-
albumin-expressing (PV+), fast-spiking interneurons, and
cholecystokinin-expressing (CCK+) regular-spiking interneurons
(Freund and Katona, 2007; Bartos and Elgueta, 2012). A third
type, the PV+ axo-axonic interneurons (often referred to as
“chandelier cells” especially in the neocortex, e.g., Povysheva
et al., 2013), innervates only the initial segments of PC axons; we
will not discuss axo-axonic cells in detail.
The CCK+ and PV+ BCs differ in a number of fundamental
features (Freund and Katona, 2007; Bartos and Elgueta, 2012). In
addition to differences in firing patterns—non-accommodating,
γ-synchronized action potentials in PV+ BCs; accommodating,
poorly γ-synchronized action potentials in CCK+ BCs—one
other distinction is that CCK+ BCs express the main receptor for
the cannabinoids, CB1R, while PV+ BCs express the mu-opioid
(µOR) receptor (Drake and Milner, 2002), which responds to cer-
tain opioids. Traditional anatomical and physiological evidence
suggests that these two receptor populations have virtually no
overlap (recent evidence that suggests this conclusion should be
modified will be discussed below). These distinctions between
PV+ and CCK+ BCs hold for both hippocampus and cortex, but
not everywhere. For example, in the striatum PV+ BCs express
CB1Rs (Kano et al., 2009). Additional differences between PV+
and CCK+ BCs can be found in their complement of mAChRs, as
discussed below.
A well-studied representative of the dendritic targeting class
of interneurons is the somatostatin (SOM)- and mGluR1a-
expressing interneuron. Hippocampal interneurons in this class
have their somata in the stratum oriens and the great bulk of
their axonal arbor in the stratum lacunosum-moleculare, and
are referred to as oriens-lacunosum moleculare (O-LM) cells.
O-LM cells target the dendrites rather than perisomatic regions
of PCs and have different phase preferences for firing within
θ rhythm oscillations than do the BCs (or axo-axonic cells).
Therefore O-LM cells play distinctive functional roles in regulat-
ing both PC excitability and temporal patterning of PC activity
(Buzsáki, 2002; Klausberger and Somogyi, 2008; Bartos et al.,
2011).
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These classes of interneurons are not unique to the CA1 region;
most other regions of the hippocampus and the neocortex have
similar inhibitory configurations (Lund and Lewis, 1993; Curley
and Lewis, 2012). The BCs in the neocortex have essentially the
same properties as in the hippocampus, as do the axo-axonic
cells (Curley and Lewis, 2012), although it appears the cortical
axo-axonic cells have not received as much attention as the
hippocampal ones have. In the cortex, the Martinotti cells are also
SOM+ /mGluR1α+, and target PC dendrites, and seem generally
analogous to the O-LM cells of the hippocampus. Therefore,
understanding how mAChR activation regulates these interneu-
rons and consequently the dynamics of hippocampal network
activity may be applicable to the neocortex.
mAChRs are widely distributed on the principal cells of the
hippocampus and neocortex. PCs in CA1-CA3 and granule cells
in dentate gyrus all have abundant postsynaptic expression of M1
receptors, and weaker expression of M3 receptors (Levey et al.,
1995). Activation of M1 or M3 usually increases cellular excitabil-
ity. Therefore, the most dramatic direct effect of either exoge-
nously applied cholinergic agonists or endogenously released ACh
on PCs is a pronounced membrane potential depolarization and
decrease in membrane conductance (Dodd et al., 1981; Cole and
Nicoll, 1983; Pitler and Alger, 1990). This response, together
with a decrease of the afterhyperpolarization (AHP; Cole and
Nicoll, 1983) and the activation of a persistent, voltage-dependent
sodium current (Yamada-Hanff and Bean, 2013), often results
in sustained action potential firing (Cobb and Davies, 2005),
particularly in hippocampal CA3, where the PCs form a strong
recurrent intercollateral network. Neocortical PCs are similarly
affected by muscarinic agonists (McCormick and Prince, 1986;
Haj-Dahmane and Andrade, 1999).
For the inhibitory interneurons, the major muscarinic
response is also depolarization, but with a less prominent associ-
ated change in cell input resistance. Generalizations are somewhat
difficult to make however, given the diversity of mAChR subtypes,
interneurons, and the specific distributions of mAChRs along the
cells. For example, M1 is predominantly expressed on PCs but
found in very low abundance, if at all, on GAD67-expressing
interneurons, including O-LM cells (Yamasaki et al., 2010). These
factors make the muscarinic modulation of interneurons much
more complicated than that of the PCs. Besides the depolarizing
effects of mAChR activation, some interneurons exhibit pure
hyperpolarizations or biphasic responses, in which an initial
hyperpolarization is followed by a secondary depolarizing phase
(McQuiston and Madison, 1999a; Widmer et al., 2006; Bell et al.,
2013); the hyperpolarizing responses are attributable to activation
of M4 receptors, which activate inwardly rectifying K+ channels
(Bell et al., 2013).
Both CCK+ and PV+ BCs are depolarized by mAChR activa-
tion, but some CCK+ Schaffer collateral-associated (SCA) cells
also express M2 and M4 receptors to some extent and show
biphasic responses when a cholinergic agonist is applied (Cea-
del Rio et al., 2010, 2011). CCK+ BCs and SCA cells have strong
expression of both M1 and M3 mAChRs, while PV+ BCs and axo-
axonic cells express only M1 receptors in their somato-dendritic
regions (Cea-del Rio et al., 2010, 2011). Therefore, CCK+ cells
are more sensitive to ACh stimulation. More importantly, M3
receptor activation controls the mAChR-mediated increase in
firing frequency, and both M1 and M3 mAChR activation is
required for the full conversion of the spike AHP into a spike
afterdepolarization. mAChR activation increases action potential
duration and frequency and reduces spike adaptation in CCK+
cells, as in O-LM cells (Lawrence et al., 2006a), but not in PV+
cells (Cea-del Rio et al., 2010). On the other hand, the outputs of
both types of interneurons are also modulated by mAChRs. PV+
cells express M2 receptors on their presynaptic axon terminals;
activation of these receptors directly inhibits Ca2+ channels and
suppresses GABA release (Hájos et al., 1998; Fukudome et al.,
2004). ACh and muscarinic agonists also inhibit GABA release
from CCK+ cells, but rather than directly activating presynaptic
mAChRs, postsynaptic mAChRs on PCs reduce GABA release via
an indirect retrograde signaling mechanism, as discussed in the
section on eCBs and mAChRs, below.
The O-LM cells express both M1 and M3 receptors (Lawrence
et al., 2006a) and generate large depolarizing responses upon
mAChR activation (Kawaguchi, 1997; Widmer et al., 2006).
Besides direct depolarization by inhibition of M-current, M1 or
M3 activation also greatly accelerates action potential firing rate
and generates a prominent suprathreshold afterdepolarization in
these cells (Lawrence et al., 2006a,b).
ACh GENERATION AND MODULATION OF OSCILLATIONS
IN VIVO OSCILLATIONS IN HIPPOCAMPUS AND NEOCORTEX
Rhythmic fluctuations in cell membrane potentials produce field
potential oscillations. Depending on how many cells are syn-
chronously involved, the oscillations can coordinate neuronal
activity both locally and across brain regions and are considered
to be essential for various cognitive functions. The two most
prominent oscillations in the hippocampus are in the θ and
γ ranges, which are often concatenated such that γ activity is
observed “riding” on a θ carrier wave. ACh can have either a
causal or modulatory role in these oscillations, most notably in
the θ band, and the mechanisms by which ACh influences them
are controversial. It is generally agreed that mAChRs play a more
prominent role than nAChRs in rhythm generation.
θ-frequency firing is a basic operational mode of the hip-
pocampus, and is proposed to underlie the formation of episodic
memories and spatial maps of the environment (Buzsáki, 2005). θ
can be detected in all layers of the CA1 hippocampus, although its
amplitude and phase change with depth, with a current source
located in s. pyramidale and a current sink near the border
of s. radiatum and s.l.m. θ rhythms can modulate plasticity,
particularly at the CA3-CA1 Schaffer collateral pathway. For
instance, LTP is optimally induced if a train of electrical stimuli
coincides with the peak of the θ rhythm, and stimulation given at
θ frequency (“theta burst”) is optimal for the induction of LTP in
CA1 neurons (Larson and Lynch, 1986).
Output from the MS/DBB is necessary for generating hip-
pocampal θ-frequency rhythms in vivo, and lesioning the septum
abolishes these rhythms and decreases the rate of learning by rats
on a spatial maze task (Winson, 1978). However, the mechanisms
of θ generation are not homogeneous, and differ depending on
the behavior or state of an animal. “Type 1” θ occurs during
active, exploratory behavior and is relatively insensitive to the
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mAChR antagonist atropine. This does not mean, however, that
ACh has no role in Type I θ or associated behaviors. The mAChR
antagonist, scopolamine, reduces the positive correlation between
hippocampal θ and maze-running speed, and also diminishes the
normally sharp spatial tuning of “grid” cells in the entorhinal
cortex that provide a coordinate system for spatial navigation
and memory formation (Newman et al., 2014). It is not known
if scopalamine’s effects can be attributed to disruptions of the
network oscillations, although this seems likely. In contrast to
Type I θ, “Type II” θ occurs under urethane anesthesia and during
REM sleep, and is abolished by atropine or selective immunole-
sioning of the septal cholinergic neurons (Stewart and Fox, 1989).
Type II is often referred to as “atropine sensitive” θ. Injection
of CCh, physostigmine, or muscarine into the hippocampus of
an awake cat elicits θ rhythms in the EEG that can also be
blocked by atropine, but not by the broad spectrum nAChR
antagonist, mecamylamine (Konopacki and Goebiewski, 1992),
again suggesting that nicotinic signaling does not play a major
role in ACh associated rhythms. The causal role of ACh in Type
II θ is not without controversy; ACh release appears to lag behind
Type II θ onset during urethane anesthesia (Zhang et al., 2010).
MS/DBB cholinergic neurons fire in a manner that is phase-
locked to the hippocampal θ rhythm in vivo (Brazhnik and Fox,
1997), although given the slow kinetics of mAChR activation
and the bulk or volume transmission that probably characterizes
most ACh release, the cholinergic cells are unlikely to be true
pacemakers for θ rhythms.
Higher frequency γ oscillations in the hippocampus may act in
concert with θ oscillations to encode and retrieve memory traces
(Bragin et al., 1995; Csicsvari et al., 2003). γ and θ can occur
concurrently, particularly in deeper hippocampal layers, and γ
is strongest during periods of θ (Bragin et al., 1995; Buzsáki,
2005). A cross-frequency correlation (CFC) analysis showed that
the degree of θ–γ coupling in CA3 in vivo increased during a
context learning task in rats, and the strength of the coupling
was directly correlated with the increase in performance accuracy
(Tort et al., 2009). Their interaction provides a mechanism for
the temporal ordering of individual episodic events (θ) and the
reconstruction of different facets of a memory (γ). The latter, the
so-called “binding phenomenon”, occurs when disparate cortical
areas encoding different facets of a memory, such as the shape,
color, and texture of an object, must be activated simultaneously
in order to form a coherent representation of the object (Singer
and Gray, 1995). However, the hypothesis that neural synchrony
through coherent γ oscillation solves the binding problem is
controversial. γ rhythms have also been proposed to provide the
exact temporal framework for spike-timing-dependent plasticity
to occur, as θ oscillations would be too slow for the rapid and
precise coordination required (Axmacher et al., 2006).
GABA inhibition is widely agreed to be a major factor in
the generation of γ (Whittington and Traub, 2003; Whittington
et al., 2011). Nevertheless, the details of the connection between
endogenous ACh in hippocampus are less clear for γ than for
θ rhythms. Atropine reduces hippocampal γ power in awake,
behaving animals (Leung, 1985; Hentschke et al., 2007), and
reduces θ–γ coupling (Hentschke et al., 2007). In vivo, how-
ever, hippocampal γ is abolished by lesioning the entorhinal
cortex (Buzsáki, 2002, 2005), suggesting a requirement for
glutamatergic, but not cholinergic, inputs in the generation of γ.
After this ablation a somewhat slower γ appears in CA3 and CA1,
suggesting that, under some conditions, the hippocampus can
generate a form of γ without the extrinsic glutamatergic inputs
from the entorhinal cortex. One hypothesis is that ACh could
trigger the intrinsic γ oscillations: γ can be pharmacologically-
induced by CCh in hippocampal slices (Fisahn et al., 1998; Traub
et al., 2003). Muscarine-induced γ rhythm in the CA3 region in
vitro depends on the activation of M1 mAChRs in PCs, and is
absent in M1 mAChR−/−mice. This M1-dependent γ is produced
by modulation of the mixed-cation Na+/K+ current and the Ca2+
-dependent non-selective cation current, but does not involve
modulation of the M-current (Fisahn et al., 2002).
Although ACh-induced oscillations are prominent in the hip-
pocampus, other brain regions can generate them locally as well,
especially the neocortex. Stimulus-evoked γ activity in visual
cortex is blocked by intracortical infusion of atropine (Rodriguez
et al., 2004), for example. Unlike the MS/DBB cholinergic pro-
jection, which drives primarily the lower frequency θ oscillations
in the hippocampus, the NBM is believed to underlie corti-
cal “activation”, or a decrease in lower frequency synchronized
EEG activity accompanied by an increase in local γ frequency.
Such a mechanism may underlie, among other things, selective
attention (review by Wang, 2010). The discharge rate of NBM
cholinergic neurons is much higher during cortical activation,
ACh release in the cortex is higher, and lesions of NBM decrease
both cortical ACh release and cortical activation (Dringenberg
and Vanderwolf, 1998). Despite a lack of direct projections to
the hippocampus, activity in the NBM does affect hippocampal
activity, and lesions of the NBM can modulate event-related
oscillations in the delta (δ, 0.1–3 Hz), θ, β (15–29 Hz), and
γ frequency ranges in dorsal hippocampus, as well as in the
amygdala and pre-frontal cortex (PFC). Cholinergic neurons in
the MS/DBB and NBM could modulate oscillations between and
within brain regions, respectively—excitotoxic lesions of MS/DBB
decrease γ frequency event-related oscillations in frontal cortex,
and reduce phase locking between frontal cortex and hippocam-
pus in the θ band (Sanchez-Alavez et al., 2014). Similar lesions
of NBM cause increases in frontal cortex δ and θ, decreases
in γ, and reductions in phase-locking between frontal cortex
and hippocampus in the γ band. The NBM mediates increases
in cortical δ activity during stress in the PFC (a direct target)
and retrosplenial cortex (an indirect target; Knox and Berntson,
2008).
IN VITRO MODELS OF ACh-GENERATED OSCILLATIONS IN
HIPPOCAMPUS AND NEOCORTEX
Whether ACh plays a causal or modulatory role in rhythm
generation in vivo is controversial. In vitro, cholinergic agonists
or released ACh generate rhythmic cell firing, synaptic currents,
and local field potentials (LFPs). These effects have been
reported most frequently in hippocampal slices, but also occur
in neocortical slices. Thus, the brain slice preparation has been
an invaluable tool for studying the mechanisms by which ACh
can generate oscillations at multiple levels, especially when
considering the “inverse problem” of the LFP (Buzsáki et al.,
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2012), i.e., the task of inferring microscopic variables (e.g.,
synaptic or cellular components) from macroscopic data (e.g., a
current source density analysis). Solving the “forward problem”
i.e., identifying the synaptic or non-synaptic events generating
the LFP by correlating them with the LFP, may be a prerequisite
for solving the inverse problem.
Application of CCh to hippocampal slices induces θ frequency
membrane potential oscillations and firing in a majority of cells
in CA1, CA3, and DG (Bland et al., 1988). The mixed ACh
agonist CCh induces oscillations in the LFP (Hájos et al., 2004),
membrane potentials or firing patterns (Williams and Kauer,
1997), and rhythmic inhibitory post-synaptic responses in CA1
PCs (Reich et al., 2005). It has been proposed that ACh-generated
rhythms are initiated in CA3 and transmitted into CA1 via the
Schaffer collaterals (Williams and Kauer, 1997; Fisahn et al.,
1998; Buzsáki, 2002), although using a novel slicing procedure,
Pietersen et al. (2014) report evidence for intrinsic γ generation
in CA1. In vivo Type II (atropine sensitive) θ might addition-
ally require rhythmic inhibition onto interneurons from septal
GABAergic afferents (Stewart and Fox, 1990; Tóth et al., 1997;
Buzsáki, 2002). These models cannot explain all of the data
however, since θ-frequency rhythmic sIPSP/Cs in CA1 PCs can
be induced by CCh application to slices in the presence of iGluR
antagonists (Figure 2C; Reich et al., 2005; Karson et al., 2008) or
in small isolated sections of CA1 (Reich et al., 2005).
Rhythmic inhibition is thought to be essential for the genera-
tion of hippocampal oscillations, including ACh-mediated oscil-
lations (Stewart and Fox, 1990; Buzsáki, 2002; Mann and Paulsen,
2007; Klausberger and Somogyi, 2008). Electrical stimulation of
cholinergic afferents in hippocampal slices increases the frequency
of spontaneous IPSPs in CA1 PCs (Pitler and Alger, 1992b).
Stimulation of single hippocampal BCs at θ frequency produces
unitary IPSPs in synaptically connected PCs that are sufficient to
entrain the PC firing (Cobb et al., 1995). As noted earlier, most
interneuron types in CA1 are modulated by ACh (McQuiston and
Madison, 1999a,b; Widmer et al., 2006). Hippocampal interneu-
rons are very heterogeneous, and different interneuron classes will
fire in a distinct pattern (or not at all) within a given type of
oscillation (Klausberger et al., 2003).
The two populations of perisomatic-targeting interneurons,
PV+ and CCK+ BCs, are activated by ACh (Karson et al., 2009;
Cea-del Rio et al., 2010), and have been functionally implicated
in fast and slow oscillations, respectively, generated by cholinergic
agonists (Reich et al., 2005; Gulyás et al., 2010). Fast, iGluR-
mediated excitatory stimulation of PV+ cells produces IPSPs that
contribute to atropine-insensitive, but not atropine-sensitive θ
rhythms (Korotkova et al., 2010). Exogenous muscarinic agonists
or endogenous ACh activate PV+ cells (Cea-del Rio et al., 2010).
At the same time, M2 mAChR activation suppresses GABA
release from PV+ terminals, but does not entirely eliminate it
(Hájos et al., 1998; Gulyás et al., 2010). Application of CCh, or
release of endogenous ACh, generates θ frequency IPSP/Cs in
CA1 PCs which can be disrupted by exogenous or endogenous
cannabinoids, suggesting that ACh generates θ in CA1 by
activating CCK+ BCs (discussed below, and cf Cea-del Rio et al.,
2012). In addition to the perisomatic-targeting interneurons,
the dendritic targeting O-LM cells exhibit rhythmic membrane
potential oscillations in response to CCh application, even in the
absence of fast glutamatergic signaling (Chapman and Lacaille,
1999; Lawrence, 2008).
In CA3, CCh application generates γ-frequency oscillations
(Hájos et al., 2004; Oren et al., 2006, 2010). The γ LFPs are
greatly suppressed by a µOR agonist (µORs are predominantly
located on PV+ terminals, where their activation suppresses
GABA release), and PV+ BCs show the highest degree of phase
modulation by the LFP (Gulyás et al., 2010). In vitro, morphine
also suppresses CA3 γ rhythms that arise from tetanic stimulation
of the s. oriens, and this effect is blocked by the µOR antagonist
cyprodime (Whittington et al., 1998). Thus, it would appear that
in CA3, unlike in CA1, ACh generates oscillations by selectively
activating the PV+ network.
Whereas θ and γ are the two prominent ACh-generated oscil-
lations in hippocampus, several different frequency ranges have
been observed in neocortical slices. Unlike hippocampal slices,
where atropine-sensitive θ or γ oscillations can be reliably elicited
by CCh alone, oscillations in neocortical slices are frequently gen-
erated by applying kainate, or GABA-A receptor antagonists along
with CCh. For example, CCh application generates β oscillations
in rat PFC (van Aerde et al., 2009). The combination of CCh
plus kainate also elicits β oscillations in primary motor cortical
slices that are unaffected by AMPA blockers but prevented by
GABA-A or a gap junction blocker (carbenoxolone) (Yamawaki
et al., 2008). CCh generates β activity in an intact preparation
of newborn rat neocortex that is dependent on mAChRs and
AMPA/kainate receptors, but not GABA-A receptors (Kilb and
Luhmann, 2003). CCh plus kainate elicits γ in somatosensory and
visual cortex slices (Oke et al., 2010). Both CCh and bicuculline
application are required to generate oscillations in neonatal rat
cortical slices (Lukatch and MacIver, 1997). CCh and bicuculline
also generate 3–22 Hz LFP activity in slices of occipital lobe,
including “spiral” waves (Huang and Hsu, 2010). Thus, the dif-
ferences in frequency ranges and pharmacology of ACh gener-
ated oscillations in neocortical slices might reflect the different
circuitry activated by ACh in various cortical regions.
eCBs AND mAChRs
Depolarization-induced suppression of inhibition (DSI) is pro-
found, reversible disinhibition of principal cells that was initially
described in the hippocampus as a transient suppression of sIPSPs
or sIPSCs that followed a brief, 1 or 2 s, depolarizing current
injection into a CA1 PC (Pitler and Alger, 1992a). A great deal
of evidence showed that DSI was mediated by a retrograde signal
process, i.e., as a result of Ca2+ entry into a PC, a chemical mes-
senger was released and traveled backwards across the synaptic
cleft, and by activating an initially unidentified G-protein cou-
pled receptor on certain GABAergic nerve terminals, temporarily
prevented GABA release (Alger, 2002, for review). CCh markedly
increased IPSP frequency by activating mAChRs on hippocampal
interneurons (Pitler and Alger, 1992b) and in addition enhanced
and prolonged DSI (Pitler and Alger, 1992a). nAChRs were
found to have no role in enhancing DSI (Martin and Alger,
1999): nicotine did not mimic the effects of CCh and a broad
spectrum nAChR-antagonist, mecamylamine, did not antagonize
them. In contrast, the CCh-effects on DSI were abolished by
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FIGURE 2 | Carbachol (CCh) elicits persistent occurrence of large,
rhythmic inhibitory synaptic responses in hippocampus and neocortex.
(A) Representative whole-cell recording from a Sprague/Dawley rat CA1
pyramidal cell (PC) in control saline (iGluR antagonists present in experiments
shown in all panels) in vitro and a 1-s depolarizing voltage-step (downward
triangles) has no effect on the small spontaneous IPSCs visible on the
baseline. Bath application of 3 µM CCh induces a persistent barrage of large
IPSCs that are transiently interrupted by the periods of DSI that occur after
the voltage steps (From Martin and Alger, 1999; with permission). (B)
Representative trace from a layer II/III neocortical PC from a Swiss CD-1
mouse slice. A large barrage of IPSCs occurs after CCh (5 µM) is added to the
bath, and the IPSCs are suppressed by further addition of the CB1R agonist
WIN55212-2 (5 µM). From Trettel et al. (2004) with permission.
(Continued )
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FIGURE 2 | Continued
(C1) Representative sharp electrode recording of large, rhythmic IPSPs
induced by 5 µM CCh in a rat CA1 PC in a hippocampal slice. Brief bursts of
action potentials induced by depolarizing current injections induced a period
of DSI. (C2) Power spectral analyses of the IPSPs before, during and after
DSI. Note peak power in the theta frequency range. (C3) Group data
showing “relative theta power” (integral of power from 4–14 Hz/total power
from 2–50 Hz) from experiments as in C1, C2. DSI strongly suppressed the
theta power (which recovered fully following DSI). DSI was abolished by the
CB1R antagonist, AM251 (3 µM). From Reich et al. (2005) with permission.
(D) DSI of 5 µM, CCh-induced IPSPs produced by an action potential train
in a layer II/III PC in a mouse neocortical slice. DSI was abolished by 5 µM
AM251. From Trettel et al. (2004) with permission.
atropine and other mAChR antagonists, and were mimicked by
selective mAChR agonists, such as Oxo-M. A battery of mAChR
antagonists, including pirenzepine, 4-DAMP, and AFDX-116, led
to the conclusion that either the M1 or M3, but not the M2
receptor, were responsible for inducing persistent action potential
firing of the interneurons that were most highly sensitive to DSI
(Martin and Alger, 1999; cf Trettel et al., 2004), i.e., the firing of
these interneurons produced GABAergic IPSCs that were readily
suppressed by DSI (Figure 2). The results explained the great
sensitivity of CCh-induced sIPSCs to DSI, but provided no insight
into the actual mechanism of DSI itself.
In 2001 the retrograde messenger for DSI was reported to
be an eCB, and the GPCR-coupled receptor on the interneu-
ron terminals was the cannabinoid receptor, CB1R (Ohno-
Shosaku et al., 2001; Wilson and Nicoll, 2001). There are
two major eCBs, anandamide and 2-arachidonyl glycerol (2-
AG), and 2-AG was demonstrated to be the main signal-
ing eCB (see Kano et al., 2009 for review and Figure 1
DSI). It was soon found that a mGluR agonist, (±)-1-
aminocyclopentane-trans-1,3-dicarboxylic acid (ACPD) or the
selective group I mGluR agonist, (S)-3,5-dihydroxyphenylglycine
(DHPG), markedly increased DSI (Varma et al., 2001). At low
concentrations, DHPG enhanced DSI without affecting the IPSCs
directly, while at higher concentrations DHPG directly suppressed
the IPSCs as well. Most significantly, the three phenomena, DSI,
the enhancement of DSI by mGluRs, and the direct suppression
of IPSCs by high concentrations of an mGluR agonist were all
abolished by a CB1R antagonist, and absent in the CB1R−/−
mouse. The explanation was that mGluRs on PCs either enhanced
the mobilization of eCBs by DSI, or directly caused eCB mobiliza-
tion from these cells, and the eCBs crossed the synaptic cleft and
inhibited the IPSCs by activating the CB1Rs on the interneuron
terminals (Figure 1; “mobilized” is the preferred term because the
processes of eCB synthesis and release cannot be distinguished
electrophysiologically and are not inextricably linked, see Alger
and Kim, 2011, for review). eCBs are also retrograde signals
at excitatory synapses (Kreitzer and Regher, 2001) and mGluRs
mobilize eCBs there as well (Maejima et al., 2001). Thus eCBs
are not only produced by high levels of Ca2+ in principal cells,
but are intermediaries in modulating synaptic transmitter release
by glutamate, and hence were likely to have a broad range of
actions.
Both group I mGluRs and M1-class mAChRs are GPCRs
that are coupled to Gq/11 type G-proteins. Kim et al. (2002)
found that activating mAChRs with low µM concentrations
of CCh markedly enhanced DSI without affecting the IPSCs
directly, but at higher concentrations directly suppressed them.
For concentrations up to ∼5 µM CCh, the suppressive effects on
the IPSCs were entirely reversed by a CB1R antagonist, demon-
strating that, like the type I mGluRs, mAChRs could mobilize
eCBs. Above 5 µM, a portion of the CCh-induced IPSC sup-
pression could not be prevented by CB1R antagonists, suggesting
that a distinct, eCB-independent form of synaptic depression also
occurred. Significantly, bath-application of the AChE inhibitor,
physostigmine, in the absence of other treatments, induced an
atropine- and CB1R-dependent suppression of IPSCs, indicating
that the low, tonic levels of ACh present in hippocampal slices
were sufficient to induce persistent mobilization of eCBs (Kim
et al., 2002). In accordance with this suggestion, Colgin et al.
(2003) found that an AChE inhibitor depressed fEPSPs in the
dentate gyrus and CA1 of hippocampal slices. This effect was
absent when, prior to the in vitro experiments, the fimbria/fornix
was lesioned and allowed to deteriorate. Most importantly, the
effect was abolished by atropine and a CB1R antagonist, but
unaffected by an M2 mAChR inhibitor, clearly arguing that ACh
from cholinergic afferents could suppress glutamate transmission
heterosynaptically via mAChR-induced, eCB release. Presumably
in vivo release of ACh can have the same ability to regulate synap-
tic transmission indirectly by stimulating the release of eCBs. It is
important to note that, in addition to glutamate and GABA, eCBs
may also directly regulate the release of ACh itself (Gifford and
Ashby, 1996; Kathmann et al., 2001; Tzavara et al., 2003; Degroot
et al., 2006), although detailed physiological mechanisms of these
effects have yet to be worked out.
Neither the mAChR-dependent increase of DSI, nor the direct
mobilization of eCBs by mAChR activation was associated with
any change in [Ca2+]i (Kim et al., 2002), suggesting that the
GPCR-dependent pathway of eCB mobilization and the Ca2+
-dependent pathways were independent. Indeed, the ability of
mAChRs to mobilize eCBs was occluded when GTPγS, a gen-
eralized activator of G-proteins, was infused into the cells, but
unaffected when intracellular Ca2+ was chelated by high con-
centrations of intracellular BAPTA (Kim et al., 2002). Hence,
mAChR-dependent eCB mobilization is independent of changes
in [Ca2+]i but entirely dependent on G-protein activation,
whereas, conversely, DSI is totally dependent on a rise in [Ca2+]i
and unaffected by GTPγS. Thus the two pathways for eCB mobi-
lization are independent, but, importantly, can interact, as shown
by the enhancement of DSI (Ca2+-dependent pathway) by co-
activation of a GPCR pathway (Varma et al., 2001; Kim et al.,
2002).
The findings on mAChRs and eCBs were confirmed and
extended in paired recordings from principal cells and interneu-
rons in tissue-cultured primary hippocampal neurons (Ohno-
Shosaku et al., 2003). Ohno-Shosaku et al. (2003) observed no
real change in the ability of CCh (or Oxo-M) to mobilize eCBs
in tissue cultured cells from knock out mice with either M1−/−
or M3−/− mAChRs eliminated, but a virtual elimination of the
eCB-related effects in the combined M1−/−/M3−/− line. This
demonstrated involvement of both M1 and M3 mAChRs, and
suggested that activation of either receptor alone could produce
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enough eCBs for maximal suppression of IPSCs. In the dorsal
striatum, tonic activity of the cholinergic interneurons leads to
a persistent enhancement of DSI in the medium spiny neurons,
which is blocked by the M1 antagonist, pirenzepine, and is absent
in the M1−/− mouse, and hence is also mediated via M1 mAChRs
(Narushima et al., 2007).
Although these issues have not been dissected as thoroughly
in the neocortex as in the hippocampus, the apparently identical
observations of IPSC frequency enhancement by CCh and eCB-
dependent DSI in neocortical slices (Figure 2; cf. Fortin et al.,
2004; Trettel et al., 2004; Yoshino et al., 2011) makes it likely that
the association between M1/M3 receptors and eCBs holds there
as well. Fukudome et al. (2004) showed, also in paired principal
cell-interneuron recordings in hippocampal tissue-culture, that
the eCB-independent, CCh-induced suppression of GABA release
was mediated by M2 receptors, as it was mimicked by the M2 pre-
ferring agonist, gallamine, and absent in tissue from the M2−/−
mouse. Importantly, the M2-mediated suppression occurred in
those interneurons that were not sensitive to suppression by eCBs,
and vice versa, interneurons from which GABA release was sup-
pressed by eCBs were insensitive to suppression by gallamine. It
is therefore likely that the interneurons from which GABA release
is inhibited indirectly by M1/M3 (i.e., eCB-sensitive) actions and
those inhibited by M2 mAChRs are of different classes. Undoubt-
edly, the former represented the CCK+/CB1R+ interneurons and
the latter the CCK−/CB1R− interneurons, probably the PV+
cells, although the cells were not immunologically identified. The
results from slices (Martin and Alger, 1999; Kim et al., 2002)
and tissue-culture (Ohno-Shosaku et al., 2003; Fukudome et al.,
2004) are in substantial agreement in identifying the M1/M3
receptors as the likely stimulants of the eCB mobilization, while
M2 receptors mediate an eCB-independent form of presynaptic
inhibition.
Studies with tissue from phospholipase C beta (PLCβ)
isoform-specific, knock-out mice, PLC−/−β 1 and PLC
−/−
β 4 showed
that PLCβ is an essential element in the G-protein signaling path-
way between mAChRs, or mGluRs, and eCBs in hippocampus
and cerebellum, with the different isoforms being predominant in
different brain structures (Hashimotodani et al., 2005; Maejima
et al., 2005); in the absence of PLCβ neither of these GPCRs can
mobilize eCBs. Another key observation was that DSI is inde-
pendent of PLCβ (Hashimotodani et al., 2005), which confirms
that the Ca2+ -dependent and GPCR-dependent forms of eCB
mobilization utilize distinct biochemical pathways, although 2-
AG is the eCB produced by both of them. PLCβ is activated by
M1/M3 mAChRs and requires Ca2+ for its enzymatic activity,
hence it is proposed that PLCβ acts as a coincidence-detector
(Hashimotodani et al., 2005) that can integrate the actions of
Ca2+ and G-proteins and thereby explain the ability of mAChRs
to enhance DSI. Some challenges to this straightforward story
exist (Edwards et al., 2006, 2008) and future work should pro-
vide more mechanistic detail. Nevertheless, PLC is a part of the
molecular cascade that produces 2-AG, though not anandamide,
and so the involvement of PLC also confirmed that 2-AG was
the major eCB produced by mAChRs. 2-AG is produced by the
enzyme diacylglycerol lipase alpha (DGLα) and the absence of this
enzyme in DGL−/−α mice prevents the mAChRs from mobilizing
eCBs (Tanimura et al., 2010; Yoshino et al., 2011). DSI is also
absent in DGLα−/− mice (Gao et al., 2010; Tanimura et al.,
2010; Yoshino et al., 2011), unlike the case with PLCβ−/− mice
in which DSI is unaffected. Evidently, if diacylglycerol is the
common precursor for the production of 2-AG, two indepen-
dent pathways supply diacylglycerol to DGLα for the production
of 2-AG.
The summary picture is that M1 and M3 mAChRs mobi-
lize the eCB 2-AG via a molecular pathway involving PLCβ
and DGLα.
OPTOGENETIC STUDIES
Release of endogenous ACh via bulk tissue electrical stimulation
activates interneurons in hippocampus (Pitler and Alger, 1992b;
Widmer et al., 2006), and drives inhibitory oscillations in CA1
PCs (Martin and Alger, 1999). However, bulk stimulation
of tissue can also affect non-cholinergic fibers and glia, and
complete pharmacological isolation of ACh responses is often not
possible. The advent of optogenetics has allowed for stimulation
or silencing of specific neuron populations in slice preparations
as well as in vivo, and the cholinergic system was one of the
first targeted for optogenetic manipulation (see Fenno et al.,
2011, for review). Expression of the light-activated non-selective
cation channel, Channelrhodopsin2 (ChR2, Boyden et al.,
2005), in cholinergic neurons allows for specific stimulation
of cholinergic cells or fibers and release of endogenous ACh in
slice preparations. ChR2 is commonly delivered in vivo to target
nuclei via an adeno-associated virus (AAV) vector, which has a
high tropism for neural tissue and can result in expression levels
exceeding 90% in target cells (Figure 3). To ensure specificity
of ChR2 expression in cholinergic cells, the cre-loxP system has
been utilized: the vector constructs carry a double-floxed inverted
(FLEXED) ChR2 sequence (Atasoy et al., 2008), and the vectors
are injected into the brains of ChAT-Cre mice, which express cre
recombinase only in cholinergic cells. Injection of AAV-ChR2
into cholinergic nuclei results in expression of ChR2 in distal
axon terminals of projection neurons in ∼2–5 weeks (Figure 3A;
cf Gu and Yakel, 2011; Nagode et al., 2011, 2014; Tang et al., 2011;
Kalmbach et al., 2012; Kalmbach and Waters, 2014), allowing for
stimulation of ACh release in slice preparations which do not
retain the cholinergic cell bodies (e.g., the hippocampus). The
variability in expression time may have to do with differences in
viral serotype used (AAV2/1—2/9 have all been used), viral titer
(typically higher than 1012 genome copies/ml), or ChR2 variant.
In general the AAVs appear to have equal tropism for all cells,
although selective transformation of inhibitory cells in the cortex
was reported with low titer levels (e.g., Nathanson et al., 2009) and
specific tropism for cholinergic neurons has apparently not been
reported. AAV2/1, 2/5, and 2/9 have all been used successfully
with the cre/lox strategy in the Chat-Cre mice. The ChR2-variant,
ChIEF, which has faster kinetics, hence greater suitability for high
frequency stimulation, and increased steady-state photocurrent,
than does the more commonly used H134R ChR2, has also been
targeted to septal cholinergic cells and used to stimulate ACh
release in hippocampal slices (Bell et al., 2011, 2013). ChIEF
appears to show superior expression and transport to plasma
membranes when compared to H134R ChR2 (Mattis et al., 2011),
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FIGURE 3 | Release of ACh by light-stimulation of ChR2 in
ChAT-expressing axons induces bursts of rhythmic IPSCs in the
CA1 region of hippocampal slices. (A1) Examples of ChAT-positive
cells in MS/DBB expressing ChR2+mCherry following viral injection of
AAV (see text) into a ChAT-Cre mouse (from Nagode et al., 2011, with
permission), and (A2) ChR2+mCherry axons plus DAPi staining
showing cholinergic axons in proximity to cells in CA1. Details of
procedures are found in Nagode et al. (2011). (A3) Diagram of
experimental setup; light-stimulation of ChR2-expressing axons in CA1
release ACh onto CCK+ interneurons that fire trains of action
potentials and thereby induce IPSPs in CA1 PCs. Sample trace to the
right shows trains of blue-light pulses (blue triangles) given at 2 min
intervals gradually come to induce prolonged bursts of GABAergic
IPSCs (downward deflections in the presence of iGluR blockers to
prevent EPSC occurrence in experiments shown in this panel; cf.
expanded portion, below) in a PC. A 2-s voltage step was given to
the PC near the end of the trace (red arrow) to induce DSI, the
transient interruption of the IPSCs. (A3b,c) Autocorrelation function
and power spectrum of data from this cell illustrate the rhythmic
nature of the ACh-induced IPSCs. Neither physostigmine nor 4-AP
were used in this experiment. (B) Top trace, light pulse (blue bar)
delivered to ChR2-expressing axons in a slice from a ChAT-Cre,
AAV-injected mouse induced a burst of large IPSCs in a CA1 PC;
second trace, the burst of IPSCs was interrupted during the period of
DSI produced by a brief depolarization of the PC; third trace, recovery
of the IPSC burst after the DSI trial; fourth trace, application of the
GABA-A receptor antagonist, gabazine, blocks all light-induced activity,
confirming their identity as IPSCs. Physostigmine, 1 µM, and 4-AP, 20
µM, were present in the bathing solution. Results are typical of
numerous experiments. (A2, B) from D.A. Nagode Ph.D. thesis at
http://archive.hshsl.umaryland.edu/handle/10713/2315. (A3a–c) is a
typical result (c.f. Nagode et al., 2011).
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although whether this translates into advantages of ChIEF over
H134R ChR2 for release of ACh from terminals is not yet known.
In addition to the viral strategy, transgenic mouse lines
constitutively expressing ChR2 have been developed. The most
widely-used strain is the ChAT-ChR2-EYFP mouse (Strain
014546; Jackson Laboratories; e.g., Ren et al., 2011; Pinto et al.,
2013). In vivo stimulation of basal forebrain ACh neurons, or
their axon terminals in visual cortex, has also been achieved
using this mouse. Pinto et al. (2013) found that ChR2 activation
of basal forebrain cell bodies or axon terminals desynchronized
cortical activity and enhanced visual discrimination. On the other
hand, crossing Chat-Cre mice with the inhibitory halorhodopsin
or archerhodopsin-expressing mice to silence basal forebrain
cholinergic neurons synchronized cortical activity and decreased
visual discrimination. However, the ChAT-ChR2-EYFP strain
exhibits some deficits in attention and working and spatial
memory, due to increased copy number and expression of VAChT
(Kolisnyk et al., 2013), which should be considered before using
them, especially for behavioral studies. Indeed, because efficiency
of optogenetic activators or silencers is low, the high protein
expression required to affect neuronal activity, especially during
brain development, might permanently alter brain circuitry and
therefore behavior. The expression of opsins in ChAT-Cre mice
also varies across brain regions. The viral transduction method
in adults, though more invasive, may be more advantageous than
constitutively expressing mouse models in some cases.
It must be noted that in some parts of the nervous system ACh
is reportedly co-localized with other neurotransmitters, including
glutamate (e.g., Allen et al., 2006; Lamotte d’Incamps and Ascher,
2008) and GABA (Bayraktar et al., 1997, but see Chédotal et al.,
1994), and furthermore that they may be co-released with ACh
(e.g., Allen et al., 2006; Lamotte d’Incamps and Ascher, 2008;
Ren et al., 2011). In principle co-release of glutamate by ChR2-
induced depolarization could confound studies of optogenetic
ACh release. Although we have seen no evidence for this in our
experiments (Nagode et al., 2011, 2014), the possibility should
be explored. Therefore, even precise cellular targeting of light-
activated molecules to ChAT-expressing cells may not absolutely
guarantee that light stimulation will cause the release of only
ACh, or conversely, that any light-induced biological effects can
unambiguously be attributed to ACh a priori. This will probably
be true whether the opsins are expressed in the target cells
virally or transgenically. Additional pharmacological or perhaps
molecular biological controls would have to be taken to identify
the active agent. For the use of pharmacological tools, in vitro slice
preparations will undoubtedly be most effective. Of course, from
the point of view of behavioral relevance, in vivo preparations
will be most desirable. Thus, it seems that combinations of in
vivo and in vitro approaches will be required to achieve definitive
conclusions regarding axonally released transmitter actions, even
using optogenetic techniques, for the forseeable future.
For the study of ACh effects in slice preparations, particularly
oscillations or other network phenomena, generating sufficient
ACh release is a significant concern. ChR2 expression in axon
terminals is usually weaker than in somata, and axons from the
basal nuclei are unavoidably severed by the slicing. If the “bulk
transmission” hypothesis is correct (Vizi and Kiss, 1998), large
amounts of ACh release might be required to activate receptors
on target cells, especially since acetylcholinesterase (AChE)
hydrolyzes ACh very efficiently. It is nevertheless possible to
stimulate long bursts of DSI-sensitive IPSCs that closely mimic
those induced by mAChR agonists (e.g., Figures 3, 4). While
these IPSCs can be elicited by light-induced ACh release in slices
in normal recording saline (Figure 3A), we (Tang et al., 2011;
Nagode et al., 2011, 2014) often use physostigmine to inhibit
AChE, and a low concentration of the K-channel blocker, 4-AP, to
enhance ChR2-induced ACh release (as has been done by others,
e.g., Petreanu et al., 2007; Hull et al., 2009). This greatly increases
the occurrence of ChR2-induced rhythmic activity without
otherwise altering the IPSCs (Figures 2B and 3; cf Nagode et al.,
2011). Such pharmacological enhancement is not necessary for
evoking post-synaptic ACh currents (Bell et al., 2011, 2013) or
nAChR-dependent plasticity of EPSCs in CA1 PCs (Gu and Yakel,
2011), suggesting that less ACh is required to generate single cell
firing than sustained network activity.
An important new finding (Nagode et al., 2014) was that
light-induced ACh release triggers IPSCs that are sensitive to DSI,
and that most of them are also sensitive to µOR agonists even
when the output of PV+ cells (which express the great majority
of hippocampal µORs) has been abolished (Figure 4B). Dual
CB1R/µOR sensitivity has been reported (e.g., Neu et al., 2007;
Glickfeld et al., 2008) but it was surprising to encounter it so
frequently in the optogenetic experiments. The explanation for
this observation is not understood, but may imply that axonally
released ACh has an unexpectedly strong tendency to activate
dually sensitive interneurons, which could be important for
understanding cannabinoid/opioid interactions in vivo. It will
be of great interest to explore the effects of silencing septal
cholinergic neurons with halorhodopsin or archerhodopsin in
vivo during ongoing hippocampal θ oscillations. The unique
ability to release ACh from cholinergic axons optogenetically
probably made this discovery possible.
While dramatic effects of optogentically released ACh are on
the induction of θ rhythm frequency oscillations of IPSPs via
activation of mAChRs, a pulse of released ACh also elicits a burst
of IPSCs by activating nAChRs and a highly novel mechanism
involving T-type Ca2+ channel activation and Ca2+ stores (Tang
et al., 2011). These events occur even in the presence of TTX,
strongly suggesting that the nAChRs are on the GABAergic nerve
terminals. Moreover, since there are no morphologically defined
synapses along these axons, this appears to be a direct example
of a non-synaptic effect of axonally released ACh. Non-synaptic
stimulation of GABA release can also be produced by optogenetic
stimulation of striatal cholinergic interneurons. Interestingly, the
same ionic mechanism as proposed in hippocampus (Tang et al.,
2011) appears to operate in striatum (Nelson et al., 2014).
mAChRs, eCBs, AND NEURONAL NETWORK OSCILLATIONS
IN HIPPOCAMPUS
mAChR-activation induces the firing of CCK+/CB1R+ cells and
IPSCs from these cells are a major factor in inhibitory θ rhythms.
However, there is extremely good evidence that the M1 and M3
mAChRs are also very effective in stimulating the mobilization
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FIGURE 4 | IPSCs triggered by light-induced ACh release arise from
CB1R+ interneurons. (A1) Top two traces as in Panel 3B, the CB1R
agonist, WIN55212-2 (WIN) was then applied to the bathing solution of
the same cell, and prevented the ability of ACh to induce repetitive
IPSCs. (A2–A4) Group data showing that the increases in IPSC
amplitudes (A2) or frequency (A3) or cumulative frequency (A4)
induced by light in control solution (left graphs in A2,A3), were
occluded in WIN-treated slices; i.e., that they arose from CB1R+
interneurons. (A5) Shows that pretreatment with the CB1R antagonist,
AM251, prevented the ability of WIN to suppress the ACh-induced
IPSCs. (B1) DSI-sensitive IPSCs induced by ACh release can also be
reversibly suppressed by the µOR agonist, DAMGO, and recover when
the µOR antagonist, naloxone, is applied. (B2,3) Show group data for
experiments such as in (A). Physostigmine, 1 µM, and 4-AP, 5–20 µM,
were present in the bathing solution. Figures taken from D. Nagode
Ph.D. Thesis, at http://archive.hshsl.umaryland.edu/handle/10713/2315.
of eCBs. One might expect that the GABAergic output from
CCK+/CB1R+ cells would be rapidly eliminated by the eCBs, and
indeed it has been proposed that CCh-generated eCBs silence the
CB1R+ cells during rhythm generation in CA3 (Gulyás et al.,
2010; Holderith et al., 2011). Nevertheless, on the contrary, the
CCh-induced IPSCs are highly susceptible to inhibition by DSI
(e.g., Pitler and Alger, 1992b; Alger et al., 1996; Martin and Alger,
1999; Wilson and Nicoll, 2001; Kim et al., 2002; Hampson et al.,
2003; Fortin et al., 2004; Trettel et al., 2004; Yoshino et al., 2011).
Thus the CB1R+ interneurons are not entirely silenced by the
mAChR-induced eCBs. As noted, studies from DGLα−/− mice,
which are incapable of generating the major eCB, 2-AG, confirm
that both mAChR-dependent eCB effects and DSI are mediated by
2-AG (Tanimura et al., 2010; Yoshino et al., 2011), so differences
in eCB identity cannot account for the continued sensitivity of
CCh-induced θ IPSCs to DSI.
An entirely different mechanism was described by Makara
et al. (2007) who reported that, in the presence of CCh,
the eCB-system becomes dependent on nitric oxide (NO)
production. When mAChRs were activated DSI could be
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prevented by inhibitors of NO synthesis or NO scavengers. NO
scavengers injected into the postsynaptic PCs prevented the action
of NO and soluble cGMP, a proposed intracellular target of NO,
was selectively located in presynaptic CB1R+ nerve terminals.
Hence the picture was that NO was released as a retrograde signal
from the PCs, affected cGMP in the presynaptic CB1R+ terminals
and acted in concert with eCBs to inhibit GABA release. It was
proposed that NO acted at a step downstream of CB1R, although
activation of CB1R via the synthetic CB1R agonist, WIN55212-
2, was not affected. It was unclear why eCB-mediated actions
were immune to NO in the absence of CCh. To our knowledge,
these provocative observations have not been replicated, hence
although mAChRs do generate NO at neuromuscular synapses
(Malomouzh et al., 2007; Newman et al., 2007), even interacting
with eCBs at other synapses (e.g., via M3 activation at vertebrate
neuromuscular synapses, Newman et al., 2007), a role for NO
in mAChR actions in hippocampus remains conceivable but
undefined.
Resolution of the puzzle that mAChRs both mobilize eCBs and
stimulate the activity of eCB-sensitive interneurons could well
involve a mechanism that modulates presynaptic CB1R actions
and partially offsets their depressive effects on GABA release.
Several candidates exist (Figure 5), including: (1) K+ channel
antagonists—blocking K+ channels pharmacologically can com-
pletely abolish DSI (Alger et al., 1996; Morishita et al., 1998;
Diana and Marty, 2003), probably because voltage-gated Ca2+
channel opening and intra-terminal [Ca2+]i increase when K+
channels are blocked (Varma et al., 2002). ACh-induced blockade
of presynaptic K+ channels (or other factors, e.g., retrograde
release of arachidonic acid; Carta et al., 2014) might thus over-
come CB1R-induced depression during ACh action. (2) Direct
effects on the transmitter release machinery via application of
N-ethylmaleimide (NEM), which blocks pertussis toxin-sensitive
G-proteins, increases GABA release and reverses DSI through
an unknown mechanism (Morishita et al., 1997). (3) The firing
frequency of the interneuron—the degree of eCB-mediated sup-
pression of GABA release decreases as the firing of the interneuron
increases (Losonczy et al., 2004; Földy et al., 2007). Since CCh
stimulates interneuron firing (Pitler and Alger, 1992a; Martin and
Alger, 1999; Cea-del Rio et al., 2010; Gulyás et al., 2010), the
net effect of eCBs on persistently occurring IPSCs will represent
a balance between inhibition and excitation of interneuronal
output.
If indeed mAChR-released eCBs suppress, but do not abol-
ish, CCK+/CB1R+ interneuron output, then a CB1R antagonist
should increase the IPSCs coming from these cells. That is, we pre-
dict that action of mAChRs on the interneurons will cause them
to fire and release GABA, while the CB1R antagonist will prevent
the eCBs generated by the PCs from simultaneously retarding the
occurrence of the IPSCs. Thus a given ACh stimulus should give
rise to more IPSCs in the presence of CB1R antagonism than it
normally would. While concerted effort will be required to test
this hypothesis in detail, we have observed (Nagode et al., 2011)
that indeed the CB1R antagonist AM251 increases the number
of IPSCs triggered by optogenetically released ACh (Figure 6).
This example shows that the number and mean amplitude of
the IPSCs triggered by ChR2-induced ACh release are increased
after AM251 was applied. This suggests that eCBs generated by
mAChRs can influence the IPSC rhythms. It will also be impor-
tant to determine whether similar influences can be detected on
atropine-sensitive, inhibitory rhythms in vivo, as this would sug-
gest that mAChR-induced eCBs could be involved in regulation of
persistent, behaviorally significant rhythms.
Finally, CB1R+ interneurons are electrically interconnected
(Galarreta et al., 2004) and eCBs can indirectly strengthen elec-
trical synapses (Pereda, 2014). Additionally, weakening of inhibi-
tion between electrically connected interneurons (as might occur
during enhanced eCB release), also strengthens electrical coupling
(Iball and Ali, 2011). Strengthening of electrical coupling will
enhance the synchrony of firing within such networks. Thus
complex interactions among chemical and electrical synapses and
eCBs could help to rationalize the role of mAChRs in θ inhibitory
oscillations. Unraveling the details of the modulation of eCB
actions initiated by the cholinergic system will be an important
task for the future.
mAChR DRIVEN eCB RELEASE AND ELECTRICAL SYNAPTIC
CONNECTIONS SHARPEN DISTINCTIONS AMONG
INTERNEURON CIRCUITS AND TUNE INTERNEURONAL
OSCILLATIONS
The two major BC interneuron subtypes, the CCK+ (regular-
spiking, RS) and the PV+ (fast-spiking, FS) cells are sharply
segregated by their divergent properties (Freund and Katona,
2007), including their complements of mAChRs. These cellular
and molecular differences imply that the two cell types are acti-
vated under different circumstances, by different neurotransmit-
ters and modulators, and cause different effects on their target
cells. Another factor is critical to ensuring that the cells within
each group do not act in isolation, but participate in coordi-
nated circuit based activity. As noted, electrical synaptic coupling
often exists among like cells in hippocampus and neocortex
(Galarreta and Hestrin, 1999; Gibson et al., 1999), although some
interneurons are electrically coupled to cells of different classes
(e.g., Krook-Magnuson et al., 2011). Generally, PV+ cells are
electrically coupled to other PV+ cells, but not to PCs or other
types of interneurons, including the CCK+ cells. CCK+ cells are
electrically coupled to other CCK+ cells (Galarreta et al., 2004),
but not to PCs or other types of interneurons, including the PV+
cells. The steady-state electrotonic coupling (coupling coefficient)
among the cells averages from 4–7%, meaning that, e.g., a 10 mV
change in membrane potential in one cell changes the potential
in the coupled cell from 0.4–0.7 mV. This is enough to induce a
cell to fire if it is near threshold. Injection of two random noise
signals (Galarreta and Hestrin, 1999) or small sinusoidal voltages
(Gibson et al., 1999) into two electrically coupled interneurons
can cause both of the cells to fire synchronously when either of
them reaches threshold. Thus the PV+ cells would tend to fire
together as a circuit and the CCK+ cells would also tend to fire
as an independent circuit. Interneuron circuit-wide activity will
powerfully influence PC population activity.
The existence of electrical gap junctions between the cells is
also noteworthy because it confers susceptibility to modulation
by various regulatory factors. The strength of gap junctional
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FIGURE 5 | The ability of eCBs to inhibit GABA release can be
modulated by manipulations that increase transmitter release. (A1)
Bath-application N-ethylmaleimide, an organic compound that affects
G-proteins, ion channels and other biochemical processes, increases GABA
release and abolishes the GPCR-dependent, eCB-mediated depression of
IPSCs, as well as DSI (not shown; cf. Morishita et al., 1997). (A2,A3) The
K+ channel blocker, 4-AP, increases IPSCs and abolishes
mGluR-dependent, eCB-mediated IPSC suppression and DSI. From
Morishita et al. (1998) with permission. (B) Paired recording from
mossy-fiber associated (MFA), CCK+ interneurons and CA3 PCs. (B1) Top
two sets of traces show two presynaptic action potentials in the
interneuron and the absence of a response in the PC in control saline. After
addition of the CB1R antagonist, AM251, the interneuron action potentials
reliably elicit large unitary IPSCs. (B2) A train of 50 interneuron action
potentials initially produces only a few sparse IPSCs in the PC towards the
end of the train in control solution (black trace). In the presence of AM251
(gray trace) the IPSCs are detected from the first action potential and occur
throughout the train. (B3) Group data showing the difference in the IPSC
currents, integrated within 100-ms time windows, in control and CB1R
antagonist conditions. The conclusion is that a tonic, eCB mediated
suppression of GABA release can be overcome by vigorous stimulation of
interneuron activity. From Losonczy et al. (2004) with permission.
transmission is dependent on the input (leak) resistance of the
target cells, and is frequency dependent, decreasing as the fre-
quency of the voltage deflections through the junctional channels
increases. When the leak resistance is low the coupling among
cells is also low, because the currents, instead of passing via the
gap junction into the coupled cells and depolarizing them, are
shunted through the leak resistance to the extracellular space.
When the leak resistance is high, the strength of electrical cou-
pling increases. Interestingly the PV+ and CCK+ interneurons
that are electrically coupled to each other are frequently also
chemically coupled; that is, the target postsynaptic cells receive
both electrical and chemical synaptic transmission from their
upstream presynaptic partners (Galarreta and Hestrin, 1999;
Gibson et al., 1999; Ali, 2007; Iball and Ali, 2011). The release
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FIGURE 6 | mAChR-induced IPSCs are regulated by eCBs but do not
depend on electrical coupling for their occurrence. (A) Bath application of
the CB1R antagonist AM251 increases the occurrence of IPSCs evoked by
optogenetic release of ACh (CA1 PC recording). Blue bars indicate the period
of light stimulation (5 Hz). Traces in (A2) and (B2) depict an expansion of
∼29 s of the traces (green brackets) in (A1) and (B1) beginning just before
the onset of L-IPSC activity. The increase in number and average amplitude of
the L-IPSCs caused by AM251 indicates that they had been partially
suppressed by the eCBs mobilized by ACh. Bracket at the end of (A1)
indicates approximate period of DSI after a voltage step given to the
pyramidal cell. Comparable period in (B1) shows that AM251 prevents DSI,
thus confirming that the L-IPSC activity (e.g., expanded trace in A2), despite
being partially suppressed by the long-lasting ACh-induced mobilization of
eCBs, could be further depressed by a sudden release of eCBs (i.e., DSI).
Physostigmine and 4-AP are present. (A) and (B) modified with permission
from Nagode et al. (2011). (C) Representative trace from a rat hippocampal
slice pretreated and continuously perfused with the gap junction blocker,
mefloquine (50 µM). Inset shows an expanded time scale of the indicated
region in the top trace. The autocorrelogram of the expanded region
demonstrates rhythmic, CCh-induced IPSCs despite the presence of
mefloquine. Typical results (n = 5). From D.A. Nagode Ph.D. thesis at
http://archive.hshsl.umaryland.edu/handle/10713/2315.
of GABA from CCK+ cells can be suppressed by eCBs (Ohno-
Shosaku et al., 2001; Wilson and Nicoll, 2001), and when eCBs
are released from other CCK+ cells the eCBs reduce the strength
of chemical inhibition (Iball and Ali, 2011). By decreasing the
chemical synaptic inhibition among CCK+ cells this simulta-
neously strengthens the electrical coupling between them. The
release of eCBs depresses the strengths of individual GABAergic
synapses onto other CCKs cells and increases their tendency to
fire together. Importantly, the two kinds of synaptic junctions
are independently regulated in the hippocampus; eCBs only
suppress the release of GABA, they do not affect the electrical
coupling. Thus inhibition can do more than simply veto or
permit cell firing, it can directly shift the mode of firing within
interneuronal circuits. The functional aspects of this concept
has not been explored in the context of mAChR control of
oscillations. However, given the ability of mAChRs to mobilize
eCBs, mAChR-dependent stimulation of CCK+ cell mediated
oscillations could in part reflect dual regulation of chemical and
electrical signaling, although the gap junction blocker, meflo-
quine (Cruikshank et al., 2004), did not alter the ACh-induced
θ IPSCs (Figure 6C).
PV+ cells are also electrically as well as chemically coupled and
their tendency to fire together is facilitated by electrical synapses
(Galarreta and Hestrin, 1999). Activation of mAChRs induces the
occurrence of γ rhythms driven by PV+ cells in hippocampal
CA3, but PV+ cells but do not express CB1Rs and are therefore
not directly affected by eCBs. The PV+ cell-mediated inhibitory
γ rhythms are suppressed by exogenous cannabinoids because
activation of the CB1Rs on the glutamate terminals that excite the
PV+ cells is suppressed and the resulting loss of excitatory drive
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keeps the cells from firing (Holderith et al., 2011). Surprisingly,
the eCBs released by activation of M1/M3 mAChRs on PC appar-
ently do not affect the CB1Rs on the glutamate terminals. This
conclusion follows from the observation that the CB1R antagonist
that prevents the inhibition of γ by exogenous eCBs, when applied
by itself does not alter mAChR-driven oscillations (Gulyás et al.,
2010). Given that a mAChR agonist very efficiently suppressed
GABA release via eCB action in these experiments, it is clear
that the eCBs were mobilized. Probably the eCBs simply did
not reach the CB1Rs on glutamatergic terminals. The powerful
eCB uptake and degradation systems, together with the fact
that eCBs cannot travel far from their site of production/release
(Kano et al., 2009) could have limited their movements. The
restricted actions of the eCB system help sharpen the targeting
of ACh actions, even if ACh is released in the volume conduction
mode.
Release of GABA from PV+ cells is regulated by opioids,
because these cells strongly express µORs on their nerve
terminals (Drake and Milner, 2002). Thus µOR agonists,
such as enkephalins, may have the analogous effects on the
development of PV+ driven inhibitory rhythms as eCBs do on
the CCK+ cell rhythms. Mobilization of endogenous opioids
in the hippocampus by ACh has not yet been explored in this
context to the best of our knowledge.
It is established that the CCK+ cells and the PV+ cells predom-
inate in different kinds of neuronal oscillations. The preferred
frequencies of the oscillations, γ for the PV/FS cells and the
slower θ rhythms for the CCK/RS, cells will largely be set by
intrinsic membrane properties, including the kinetics of their
AHPs, that enable the PV/FS cells to fire at higher frequency
than the CCK/RS cells, as well as by the kinetics of the chem-
ical transmission that they each mediate—IPSPs mediated by
PV/FS cells are faster than those of the CCK/RS cells. Most
importantly, the circuitry underlying the rhythms, at least in the
hippocampus, is likely to be quite different. The inhibitory θ
in CA1 is probably generated by an interconnected inhibitory
network of CCK+ cells that express CB1Rs, and perhaps also
µORs. This rhythm is independent of fast excitatory glutamater-
gic synaptic input. Rather, the rhythmic output of this circuit
is produced when the cells receive a slow cholinergic input that
activates their mAChRs for at least several seconds. Inhibitory
synaptic interactions among the interneurons then gives rise to
synchronous rhythmic firing within the network, and IPSCs are
projected onto groups of PCs. In contrast, the faster inhibitory
γ rhythms in CA3 are generated mainly by excitatory synaptic
interactions among CA3 PCs, which activate PV+ interneurons
that then feed back inhibitory inputs to the PCs. These rhythms
are abolished by iGluR blockers, or CB1R agonists, which pre-
vent stimulation of the PV+ cells; they are also abolished by
activation of µORs on the PV+ cell terminals. The schematic
diagram in Figure 7 summarizes these conclusions. Note that
this schematic is intended only to illustrate the circuitry for
the inhibitory rhythms, it does not include other circuitry such
as that described by Pietersen et al. (2014) that produces an
intrinsic γ rhythm that is entrained by cholinergic inputs and is
dependent on excitatory synaptic inputs (hence a PING model) in
CA1.
FIGURE 7 | Diagrams of two models for mACh-induced inhibitory
rhythmic IPSCs in hippocampus. Top, synaptically connected interneuron
network is tonically activated by activation of M1/M3 mAChRs on
interneurons in CA1. Interneuron firing is induced by mAChR-induced
depolarization that, when integrated with intrinsic interneuron firing
properties and incoming GABAergic IPSPs from other interneurons of the
group, generates rhythmic synchronous interneuron firing. The target PCs
receive a rhythmic barrage of IPSPs. This is analogous to the ING
(“interneuron gamma”) model of gamma rhythms. Cannabinoids interrupt
rhythms generated by this network by inhibiting the release of GABA from
the CB1R-expressing (mainly CCK+) interneurons; opioids probably inhibit
the network by acting on µORs present on a subset of the CB1R+ cells.
Note evidence of Pietersen et al. (2014) for an intrinsic γ generator in CA1
that would involve a PING mechanism. Bottom, ACh drives action potential
firing in an interconnected excitatory network (such as the CA3, but not the
CA1, PCs) as well as in the interneurons. The glutamatergic output of the
PCs excites interneurons that feed GABAergic IPSPs back onto the PCs.
Interactions between the excitatory and inhibitory cells generates the
rhythms. This is analogous to the PING (“pyramidal-interneuron gamma”)
model. Cannabinoids inhibit rhythms generated by this network by
inhibiting the release of glutamate from the PCs; opioids inhibit the rhythms
by acting on the µORs on the (mainly PV+) interneurons.
FUTURE AREAS FOR EXPLORATION OF mAChR FUNCTION IN
THE BRAIN
Despite the enormous amount of investigation into muscarinic
cholinergic systems in the brain there are still many areas about
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which little is known. We highlight a few opportunities related to
their roles of in hippocampal and cortical oscillations or behaviors
related to them.
mAChRs, PAMs, and endocannabinoids
Deficiencies in mAChR actions are implicated in various kinds of
cognitive dysfunction. Attempts to develop effective therapeutic
agents that act directly on specific brain mAChRs have not been
successful, largely because of difficulties in restricting the agents
to particular mAChR subtypes (Bubser et al., 2012). These agents
are generally agonists that bind to the active site of the molecule,
or generally enhance the availability of ACh (by preventing its
uptake, for example). In either case, side effects occur when
unintended receptors are also activated. It has been difficult to
devise agonists that only activate one mAChR subtype because
the agonist binding site is highly conserved across subtypes. An
alternative approach targets sites that are away from this highly
conserved region. Ligands at these sites, allosteric modulators, are
more specific because they bind to relatively less well-conserved
parts of the receptor molecule, i.e., sites that vary widely between
subtypes and hence offer more opportunities for specific bind-
ing. Allosteric modulators do not directly activate the receptor
but enhance the effects of ACh or other ligands that activate it
directly. For example, positive allosteric modulators (PAMs) that
are specific for M1, M4 or M5 mAChRs have been developed
(Bubser et al., 2012). In the presence of a PAM for M1, a low
concentration of ACh that produces predominantly M1 mAChR
dependent effects would increase the ability of naturally released
ACh to activate M1 selectively on its normal postsynaptic target
cells. This approach should improve the specificity of action over
the usual systemic therapeutic drug application method. Similar
strategies have been used in the case of nAChRs; e.g., the weak
AChE inhibitor and PAM of nAChRs, galantamine, attenuates
nicotine self-administration and seeking rats (Hopkins et al.,
2012).
Because activation of M1 (or M3) mAChRs potently stimulates
the release of eCBs, an M1-specific PAM should enhance the
ability of cholinergic agonists to mobilize eCBs. This hypothesis
has not been tested, but could easily be investigated in in vitro
brain slice preparations. If PAMs do facilitate eCB mobilization
by mAChRs, it might have clinical applications, particularly in
view of the preliminary results suggesting efficacy of CB1R ago-
nists in alleviating certain consequences of Alzheimer’s dementia
(agitation, lack of nutritional intact, sleep disturbances; Aso and
Ferrer, 2014). Perhaps a mAChR PAM given in conjunction with
low concentrations of a CB1R agonist would be beneficial and
further reduce the possibility of untoward side effects of either
drug alone. Alternatively, an eCB uptake inhibitor, by increasing
the concentration of eCBs near their normal site of action, might
be beneficial in boosting the eCB mobilizing ability of M1 mAChR
activation.
mAChRs, glia, and eCBs
No longer thought to be passive supporting partners of neurons,
glia are now understood to have active roles in the regulation
of synaptic transmission. Glial cells, mainly astrocytes, express a
diversity of mAChRs including M1 and M3 (Pap et al., 2009).
In several brain regions activation of mAChRs on glia cause
elevations in intracellular glial [Ca2+]i (Araque et al., 2002; Pap
et al., 2009; Takata et al., 2011; Navarrete et al., 2012). Glia
participate in the induction of synaptic plasticity in the hip-
pocampus, including a form of LTP at the CA3-CA1 synapses
that is dependent on activation of mAChRs (Navarrete et al.,
2012). Stimulation of glial mAChRs by application of cholinergic
agonists, or stimulation of ACh release from septal cholinergic
fibers causes an increase in hippocampal Ca2+ in glia (Araque
et al., 2002). In vivo sensory stimulation or electrical stimula-
tion of the MS increases Ca2+ in hippocampal astrocytes and
induces LTP of CA3-CA1 synapses (Navarrete et al., 2012). This
cholinergic LTP induction depends on activation of mAChRs and
mGluRs. Rises in glial cell Ca2+ result from activation of IP3Rs
(Takata et al., 2011; Navarrete et al., 2012), and are associated
with the release of various factors (Sul et al., 2004) including
glutamate (Halassa and Haydon, 2010, for review). Astrocytes
are also activated by endocannabinoids (Navarrete and Araque,
2008; Min and Nevian, 2012). The glial induction of LTP in
the hippocampus is caused by Ca2+-dependent glutamate release
from the astrocytes and subsequent activation of hippocampal PC
mGluRs. A similar cholinergically-driven, astrocyte-Ca2+ medi-
ated synaptic plasticity in the mouse barrel cortex is dependent
on mAChRs and NMDARs (Takata et al., 2011), indicating that
mAChR activation stimulates glutamate release there as well.
Given that glutamate activation of mGluRs is a potent stimulus
for eCB mobilization from PCs (Maejima et al., 2001; Varma et al.,
2001) elevation of glial cell [Ca2+]i should also mobilize eCBs
indirectly from the PCs following mGluR stimulation. Given the
eCB-mediated influences on cortical and hippocampal rhythms,
glia could also participate in regulation of rhythms via eCBs.
This hypothesis has evidently not been tested, but if true, would
add another potent element to the array of effects mediated by
mAChR.
mAChR regulation of rhythms by controlling ectopic axonal activity
It is generally assumed that axons simply transmit signals from
neuronal somata to synaptic terminals, and therefore that they
automatically follow somatic activity. Two corollaries follow from
this assumption: (1) somatic action potential activity is an accu-
rate guide to the activity reaching the terminals; and (2) axons do
not act independently of somata.
However, under some circumstances axonal action poten-
tials can be initiated independently of somatic depolarizations.
These were initially described in the context of disease or other
aberrant conditions, but new challenges to the simple picture
have arisen in physiological contexts. In hippocampal slices,
Dugladze et al. (2012) report that kainic acid-induced γ oscilla-
tions in the field potentials around the PCs of the CA3 region
are accompanied by much higher frequency firing in the distal
axonal branches of the PCs. Remarkably, this high frequency of
axonal firing was not reflected in the somatic action potential
firing of the PC somato-dendritic regions. It appeared that the
two cellular compartments—axon and soma-dendrite—were in
essence operating independently. When GABA-A receptors were
pharmacologically blocked, however, the axonal action potentials
did invade the somato-dendritic region, implying that normally
Frontiers in Synaptic Neuroscience www.frontiersin.org September 2014 | Volume 6 | Article 18 | 17
Alger et al. Muscarinic stimulation of inhibitory oscillations
they were actively prevented from doing so by a persistent
GABAergic inhibition. The investigators discovered that a con-
tinual high frequency firing of the axo-axonic interneurons,
which specifically target the axon hillock region of the PCs,
were responsible. In fact, a single axo-axonic cell was capa-
ble of fully controlling the antidromic invasion of the somato-
dendritic region of a PC. As noted earlier, the axo-axonic cells
in CA3 are strongly activated by mAChR activation, but the
IPSPs produced by these cells do not directly contribute to
oscillations. Rather, Dugladze et al. (2012) suggest that the
main function of the axo-axonic cells is to preserve the inde-
pendence of axonal and somato-dendritic signaling. It will be
important to determine if mAChR-induced oscillations share
the ability to modulate PC function in this novel and powerful
way.
mAChRs, eCBs, and Fragile X Syndrome
Endocannabinoid modulation of CCK+ cells may underlie some
of the deficits in oscillations in Fragile X Syndrome (FXS). In the
hippocampus of a mouse model of FXS, Fmr1−/− mice, there
is enhanced coupling of mGluRs to eCB release at inhibitory
synapses in both hippocampus (Zhang and Alger, 2010) and
striatum (Maccarrone et al., 2010). Surprisingly, the eCB actions
at excitatory synapses are actually decreased, not increased, in
this model (Jung et al., 2012). While the molecular basis for
this striking difference is not fully understood, the distinctive
molecular architecture of excitatory and inhibitory synapses will
undoubtedly constitute a major factor. DGLα is normally pre-
cisely localized in the spine heads of excitatory synapses (Katona
et al., 2006), and it has been found that the disease is associated
with an enhanced distance between mGluRs and DGLα (Jung
et al., 2012) which could explain the decreased efficiency of
eCB production. DGLα has not yet been found at inhibitory
synapses (e.g., Lafourcade et al., 2007), and the explanation for
enhanced eCB actions at those synapses is unknown, although
biochemical targets are being identified (Busquets-Garcia et al.,
2013). It should be emphasized that the functional consequences
of both decreased eCB action at excitatory synapses and increased
eCB action at inhibitory synapses will be the same: an over-
all increase in network excitability. The same could be true of
mAChR-induced eCB release, as overactive signaling through
M1 mAChRs has been hypothesized to contribute to the FXS
phenotype (D’Antuono et al., 2003). There is enhanced CCh-
induced LTD in CA1 hippocampal slices from FRX mice (Volk
et al., 2007), and M1 and M4 antagonists reduce the induction
of audiogenic seizures (Veeraragavan et al., 2011a,b). The rela-
tionship between mAChRs and eCBs deserves further study in
the context of FXS, in part because the availability of clinically
tested CB1R ligands that could be candidates for inclusion in
the therapeutic arsenal for treatment of symptoms of this serious
disorder.
CONCLUSION
Studies of the mAChR system in the brain continue to yield
exciting new insights and information on a wide variety of neu-
rophysiological problems. Undoubtedly the future holds enor-
mous promise for novel and valuable advances both in the basic
understanding of this powerful and ubiquitous regulatory system,
and in eventual clinical applications.
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